Algorae Pharmaceuticals Limited [ABN: 14 104 028 042] Level 23, Rialto South Tower, 525 Collins St, Melbourne VIC 3000 Algorae Pharmaceuticals – Notice of AGM Proceedings ASX: 1AI | 9 September 2026 Algorae Pharmaceuticals Limited (ASX: 1AI) (“Algorae” or “the Company”) advises that,...
Date of AGM and Closing Date for Director Nominations
Filed with ASX · · 1 page · English
Summary by 6ix AI
Algorae Pharmaceuticals Limited has announced the date for its upcoming Annual General Meeting, scheduled for early November. The company also specified the closing date for director nominations, which is mid-September. Further details regarding the AGM agenda and participation will be provided in the official Notice of AGM.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Notification of cessation of securities - 1AI
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- Quarterly Activities Report/Appendix 4C Cashflow Statement
- Peter Mac Testing Validates AlgoraeOS v2
Later from Algorae Pharmaceuticals
- Change of Director's Interest Notice - DH
- Notice of Annual General Meeting/Proxy Form
- Peter Mac partners with Algorae on 3rd AI validation program
- Algorae executes Licence & Supply Agreement with Umedica
- Updated Securities Trading Policy
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals